CRON, CA22717L1013

Cronos Group stock gains 27 percent in 2026 as revenue accelerates

Published on 09/22/2026 at 19:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cronos Group stock gained 27 percent through September 18, 2026, while second-quarter revenue rose 58 percent to USD 53 million. Gross margin reached 54 percent.

CRON, CA22717L1013, Illustration mit AI erstellt.
CRON, CA22717L1013, Illustration mit AI erstellt.

Cronos Group (ISIN CA22717L1013) stock had gained 27 percent through September 18, 2026, while the company's second-quarter revenue reached a record USD 53 million. The combination gives investors two distinct signals: stronger operating growth and a share price that has outpaced the broader S&P 500, which was up about 12 percent over the same period.

Revenue rises 58 percent

According to The Motley Fool on September 22, 2026, Cronos reported second-quarter net revenue of USD 53 million, an increase of 58 percent from the prior-year quarter. On a constant-currency basis, organic revenue increased 51 percent, making the underlying comparison stronger than the reported currency-adjusted figure alone.

Gross profit nearly doubled to USD 28.5 million in the second quarter of 2026, while gross margin expanded to 54 percent from 43 percent a year earlier. The margin increase of 11 percentage points matters because it shows that the revenue growth was accompanied by improved profitability at the product level.

Stock performance exceeds index

The same September 22, 2026 report placed Cronos stock at a 27 percent year-to-date gain through September 18, compared with about 12 percent for the S&P 500. That 15 percentage point performance gap is a concrete measure of the stock's relative strength, although it does not establish how the shares will perform after the reporting period.

MarketBeat listed a closing price of USD 3.35 for September 18, 2026, with a 52-week range of USD 2.28 to USD 3.61. Its snapshot also showed volume of 1.07 million shares, average volume of 1.09 million shares, market capitalization of USD 1.23 billion, a consensus rating of Hold and an average price target of USD 2.30.

Hold consensus sets a counterpoint

According to MarketBeat on September 22, 2026, the consensus price target of USD 2.30 stood below the USD 3.35 closing price recorded on September 18, while the consensus rating was Hold. The difference of USD 1.05 shows that the market price had moved ahead of the quoted analyst average, creating a valuation counter-factor alongside the operating improvement.

The next scheduled quarterly communication was listed for November 5, 2026. Until then, the key measurable test is whether the 58 percent revenue growth and the 54 percent gross margin reported for the second quarter can be sustained in the next period.

Shares remain near yearly high

Cronos Group stock closed at USD 3.35 on Nasdaq on September 18, 2026, down USD 0.02, or 0.59 percent, from the previous close. The price was USD 0.26 below the 52-week high of USD 3.61 and USD 1.07 above the 52-week low of USD 2.28 in the same MarketBeat snapshot.

Cronos Group stock at a glance

  • Company: Cronos Group Inc.
  • ISIN: CA22717L1013
  • Ticker: CRON
  • Trading venue: Nasdaq
  • Price as of September 18, 2026: USD 3.35
  • Market capitalization: USD 1.23 billion as of September 18, 2026
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Next earnings date: November 5, 2026

More news and analyses on Cronos Group stock

Disclaimer...

en | CA22717L1013 | CRON | boerse | 70158111 | bgmi